Clinical trial
A Multicenter, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of Dissolve™ Compared to Resolute™ Integrity in Treatment of Coronary Small Vessel Disease in Chinese Population
NCT03376646 is registered in ClinicalTrials.gov with DK Medical Technology (Suzhou) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of Dissolve™ Compared to Resolute™ Integrity in Treatment of Coronary Small Vessel Disease in Chinese Population
- Lead sponsor
- DK Medical Technology (Suzhou) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2018
- Completion date
- April 15, 2024
- Enrollment
- 277 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
coronary small vessel disease